Apic Bio

Today we are proud to recognize #RareDiseaseDay as we work to find cures for SOD-1 #ALS and #Alpha1. Our team is devoted to advancing potential new treatment options for these communities! Learn more: bit.ly/3JG9JG9

Apic is getting ready for #RareDiseaseDay on Monday! We look forward to tuning into events by @MassBio and @NIH, including an @AlphaFriend speaker, to rally around patient care and scientific advances! Watch with us at bit.ly/3s5Upg5 and bit.ly/3sMtqFk.

We’re thrilled to recognize many of our scientists, researchers and lab associates this International Day of Women and Girls in Science. Thanks to you and so many others at Apic for your commitment to creating #genetherapies for SOD1 #ALS and #Alpha1! #IDWGS #WomeninScience

We look forward to the 11th Annual SVB Leerink Global #Healthcare Conference next week and providing updates in 1x1s about our progress advancing our #genetherapy candidates for SOD-1 #ALS and #Alpha1. Learn more: bit.ly/3si1ecW

Our team recently had fun competing in a scientific picture contest! Thanks to everyone for submitting images showing the beauty of our #CNS and #genetherapy lab work, and to the winner, Emily, for the new picture hanging in our office.

Apic Bio looks forward to hosting virtual 1x1s alongside #JPM22 and sharing updates on our #genetherapy pipeline for #ALS and #Alpha1. Learn more about us: bit.ly/3m80ll2

November is #Alpha1Awareness Month, which Apic recognizes as we advance #genetherapy candidates to improve the lives of patients and their families affected by #Alpha1. Learn more from @AlphaFriend about this condition: bit.ly/3od0pQG

We’re a close-knit team and always appreciate opportunities to connect with each other! We recently enjoyed an outdoor escape adventure outing in Boston and put our collaboration and curiosity to good use. Learn more about us: bit.ly/3mnWgtI

Sending out a warm welcome to the new #Alpha1 Foundation @AlphaFriend President and CEO, Scott Santarella. Read more: bit.ly/3FmMFdU

Thanks to @ALSAMA for a great #WalktoDefeatALS! Our team enjoyed gathering with #ALS patients, families and other supporters in the community, and we are energized to make a difference as we advance our #genetherapy candidate. Learn more: bit.ly/3hP1aNG

We kicked off a patient speaker series to connect with people living with #ALS and #Alpha1. Thanks to our first speaker, Steve Kowalski, who shared his story about living with ALS and has inspired us with his courage and advocacy. Learn more about him: bit.ly/3knnzmH

If you’re interested in learning more about #Alpha1 and connecting with a community of patients, caregivers and healthcare professionals, don’t miss the free virtual Education Day this Saturday hosted by @AlphaFriend. Register here: bit.ly/3B1p0gD

The Apic team looks forward to participating in our third @ALSAMA #WalktoDefeatALS! Join us on October 3 as we raise awareness and support for patients and families facing #ALS with our incredible local community: bit.ly/3hP1aNG

We want to thank our summer interns for their contributions and collaboration in the lab this summer! Apic is proud to work with @ProjectOnramp to provide paid summer internships and support a diverse next generation in #biotech.

We are pleased to announce @US_FDA granted #FastTrackDesignation to APB-102, our lead #genetherapy candidate for SOD1 #ALS. Read our announcement: bwnews.pr/3rEyuKU

Thanks to @ALSAMA for hosting the #CEOSoakMA last week, and to our CEO John Reilly for representing the Apic Bio team! We were honored to participate as our Boston community raised awareness and support for local families affected by #ALS.

We look forward to the first annual @ALSAMA #CEOSoakMA this Thursday, with our CEO John Reilly participating in the soak! Join us in supporting local families affected by #ALS: bit.ly/3uMGXeU

Our team recognizes #ALSAwarenessMonth as we develop a potential gene therapy treatment for SOD1 ALS, a common cause of familial ALS.

We look forward to presenting preclinical data for our #Alpha1 Antitrypsin Deficiency #genetherapy program at the @ASGCTherapy virtual meeting. Explore the #ASGCT21 website to learn more: annualmeeting.asgct.org

We are excited to announce @FDA clearance of our IND application for APB-102, our lead #genetherapy candidate. Read our announcement: bit.ly/3sCov7P